Net income declined due to an impairment loss on investment securities
First written in FY2018. . Latest entry: FY2026-H1.
1 other company's latest entry also says "Other".
- FY2026-H1Update to gains on sales of investment securities and impairment losses for the interim periodAnnual report
「A gain on the sale of investment securities of ¥682 million was recorded as extraordinary income, while an impairment loss on investment securities of ¥452 million was recorded as an extraordinary loss.」
For the interim period, gains on sales of investment securities of ¥682 million and impairment losses of ¥452 million were recorded. - FY2025Update to full-year gains and losses on investment securitiesAnnual report
「Gain on sale of investment securities: ¥406 million」
For the full year, a gain on the sale of investment securities of ¥406 million was recorded, while an impairment loss of ¥23 million was recognized on investment securities consisting of unlisted shares. - FY2025-H1Update to gains and losses on investment securities for the six months endedAnnual report
「A gain on the sale of investment securities of ¥406 million was recorded as extraordinary income, while an impairment loss on investment securities of ¥19 million was recorded as an extraordinary loss.」
For the six months ended the second quarter, the company disclosed the recognition of a ¥406 million gain on the sale of investment securities and a ¥19 million impairment loss. - FY2024-Q3Update to gains and losses on investment securities for the nine months endedAnnual report
「A gain on the sale of investment securities of ¥180 million was recorded as extraordinary income, while an impairment loss on investment securities of ¥110 million was recorded as an extraordinary loss.」
For the nine months ended the third quarter, the company disclosed the recognition of a ¥180 million gain on the sale of investment securities and a ¥110 million impairment loss. - FY2024-Q2Update to gains and losses on investment securities for the six months endedAnnual report
「A gain on the sale of investment securities of ¥180 million was recorded as extraordinary income, while an impairment loss on investment securities of ¥66 million was recorded as an extraordinary loss.」
For the six months ended the second quarter, the company disclosed the recognition of a ¥180 million gain on the sale of investment securities and a ¥66 million impairment loss. - FY2022Update to the full-year impairment loss on investment securitiesAnnual report
「During the consolidated fiscal year, an impairment loss of ¥185 million was recognized on investment securities, consisting of unlisted shares.」
The disclosure changed from the gain-on-sale factor reported through the previous quarter to the recognition of a ¥185 million impairment loss on unlisted shares for the full year. - FY2020-Q2Update to factors affecting gains and losses on investment securities for the six months endedAnnual report
「A gain on the sale of investment securities of ¥41 million was recorded as extraordinary income, resulting in quarterly net income attributable to owners of the parent of ¥1,539 million, up 69.6% year on year.」
For the six months ended the second quarter, a gain on the sale of investment securities, rather than an impairment loss on investment securities, was recorded, and an increase in quarterly net income was disclosed. - FY2019-Q3Update to factors affecting gains and losses on investment securities for the nine months endedAnnual report
「Net income attributable to owners of the parent was ¥1,259 million, up 26.3% year on year, due to the recognition of gains on sales of investment securities and other items.」
For the nine months ended the third quarter, gains on sales of investment securities and other items, rather than impairment losses on investment securities, were disclosed as factors behind the increase in quarterly net income. - FY2019-Q2Update to factors affecting gains and losses on investment securities for the six months endedAnnual report
「Net income attributable to owners of the parent was ¥907 million, up 13.4% year on year, due to the recognition of gains on sales of investment securities and other items.」
For the six months ended the second quarter, gains on sales of investment securities and other items, rather than impairment losses on investment securities, were disclosed as factors behind the increase in net income. - FY2019-Q1Update to factors affecting gains and losses on investment securitiesAnnual report
「As a result of recording gains on sales of investment securities and other items, the amount was ¥109 million, up 182.1% year on year.」
Unlike the decline in net income caused by an impairment loss on investment securities in the previous fiscal year, gains on sales of investment securities were disclosed as a factor behind the increase in net income in the current quarter. - FY2018First statedAnnual report
「Net income attributable to owners of the parent was ¥1,533 million, down 26.0% from the previous consolidated fiscal year. The primary reason for the decline was the recognition of an impairment loss on investment securities.」
It states that full-year net income declined 26.0%, mainly due to the recognition of a ¥606 million impairment loss on investment securities.